{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:33:10Z","timestamp":1792812790599,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T00:00:00Z","timestamp":1565308800000},"content-version":"vor","delay-in-days":373,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Omics\/Marie Curie@VIB"},{"name":"KUL GOA","award":["14\/012"],"award-info":[{"award-number":["14\/012"]}]},{"DOI":"10.13039\/501100004416","name":"VLK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013276","name":"Interreg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013276","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds voor Wetenschappelijk Onderzoek Vlaanderen","doi-asserted-by":"publisher","award":["G.0929.16N"],"award-info":[{"award-number":["G.0929.16N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006668","name":"OHSU Knight Cancer Center","doi-asserted-by":"publisher","award":["NIH P30-CA069533"],"award-info":[{"award-number":["NIH P30-CA069533"]}],"id":[{"id":"10.13039\/100006668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"Department of Defense Peer Reviewed Cancer Research Program","doi-asserted-by":"publisher","award":["W81XWH-15-1-0348"],"award-info":[{"award-number":["W81XWH-15-1-0348"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001368","name":"V Foundation for Cancer Research","doi-asserted-by":"publisher","award":["V2015-024"],"award-info":[{"award-number":["V2015-024"]}],"id":[{"id":"10.13039\/100001368","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000884","name":"Cancer Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005190","name":"Melanoma Research Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005190","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.cell.2018.06.025","type":"journal-article","created":{"date-parts":[[2018,7,13]],"date-time":"2018-07-13T03:56:28Z","timestamp":1531454188000},"page":"843-855.e19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":821,"title":["Toward Minimal Residual Disease-Directed Therapy in Melanoma"],"prefix":"10.1016","volume":"174","author":[{"given":"Florian","family":"Rambow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aljosja","family":"Rogiers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oskar","family":"Marin-Bejar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Aibar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Femel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Dewaele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Karras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Hwan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Debiec-Rychter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Adriaens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Radaelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Wolter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Bechter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Dummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Levesque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano","family":"Piris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennie T.","family":"Frederick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevieve","family":"Boland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith T.","family":"Flaherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost","family":"van den Oord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Voet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stein","family":"Aerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda W.","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Marine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cell.2018.06.025_bib1","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1242\/dev.056804","article-title":"The MADS box transcription factor MEF2C regulates melanocyte development and is a direct transcriptional target and partner of SOX10","volume":"138","author":"Agarwal","year":"2011","journal-title":"Development"},{"key":"10.1016\/j.cell.2018.06.025_bib2","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/nmeth.4463","article-title":"SCENIC: single-cell regulatory network inference and clustering","volume":"14","author":"Aibar","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.cell.2018.06.025_bib3","doi-asserted-by":"crossref","first-page":"R106","DOI":"10.1186\/gb-2010-11-10-r106","article-title":"Differential expression analysis for sequence count data","volume":"11","author":"Anders","year":"2010","journal-title":"Genome Biol."},{"key":"10.1016\/j.cell.2018.06.025_bib4","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/bioinformatics\/btv715","article-title":"Destiny: diffusion maps for large-scale single-cell data in R","volume":"32","author":"Angerer","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.cell.2018.06.025_bib5","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/nprot.2012.039","article-title":"Genome-wide copy number analysis of single cells","volume":"7","author":"Baslan","year":"2012","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.cell.2018.06.025_bib6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nm.4472","article-title":"Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF\/MEK inhibitors","volume":"24","author":"Boshuizen","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2018.06.025_bib7","doi-asserted-by":"crossref","first-page":"R118","DOI":"10.1186\/gb-2008-9-7-r118","article-title":"MeV+R: using MeV as a graphical user interface for Bioconductor applications in microarray analysis","volume":"9","author":"Chu","year":"2008","journal-title":"Genome Biol."},{"key":"10.1016\/j.cell.2018.06.025_bib8","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.neuron.2014.02.039","article-title":"Prospective identification and purification of quiescent adult neural stem cells from their in\u00a0vivo niche","volume":"82","author":"Codega","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.cell.2018.06.025_bib9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.cell.2018.06.025_bib10","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1248\/cpb.47.1778","article-title":"Retinoid X receptor-antagonistic diazepinylbenzoic acids","volume":"47","author":"Ebisawa","year":"1999","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.cell.2018.06.025_bib11","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.cell.2014.03.012","article-title":"Nuclear receptors, RXR, and the big bang","volume":"157","author":"Evans","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.cell.2018.06.025_bib12","doi-asserted-by":"crossref","first-page":"905","DOI":"10.15252\/msb.20166796","article-title":"Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly dividing de-differentiated state","volume":"13","author":"Fallahi-Sichani","year":"2017","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.cell.2018.06.025_bib13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nmeth.3734","article-title":"Characterizing transcriptional heterogeneity through pathway and gene set overdispersion analysis","volume":"13","author":"Fan","year":"2016","journal-title":"Nat. Methods"},{"key":"10.1016\/j.cell.2018.06.025_bib14","doi-asserted-by":"crossref","first-page":"7037","DOI":"10.1158\/0008-5472.CAN-14-1392","article-title":"Inhibition of mTORC1\/2 overcomes resistance to MAPK pathway inhibitors mediated by PGC1\u03b1 and oxidative phosphorylation in melanoma","volume":"74","author":"Gopal","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.cell.2018.06.025_bib15","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ccr.2013.02.003","article-title":"Oncogenic BRAF regulates oxidative metabolism via PGC1\u03b1 and MITF","volume":"23","author":"Haq","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2018.06.025_bib16","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1073\/pnas.1205575110","article-title":"BCL2A1 is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibition","volume":"110","author":"Haq","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2018.06.025_bib17","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1600-0749.2006.00322.x","article-title":"Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature","volume":"19","author":"Hoek","year":"2006","journal-title":"Pigment Cell Res."},{"key":"10.1016\/j.cell.2018.06.025_bib18","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1158\/0008-5472.CAN-07-2491","article-title":"In\u00a0vivo switching of human melanoma cells between proliferative and invasive states","volume":"68","author":"Hoek","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.cell.2018.06.025_bib19","first-page":"2775","article-title":"Endothelin signaling activates Mef2c expression in the neural crest through a MEF2C-dependent positive-feedback transcriptional pathway","volume":"142","author":"Hu","year":"2015","journal-title":"Development"},{"key":"10.1016\/j.cell.2018.06.025_bib20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pbiomolbio.2012.05.001","article-title":"Tumor progression: chance and necessity in Darwinian and Lamarckian somatic (mutationless) evolution","volume":"110","author":"Huang","year":"2012","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"10.1016\/j.cell.2018.06.025_bib21","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1038\/jid.2015.105","article-title":"MITF modulates therapeutic resistance through EGFR signaling","volume":"135","author":"Ji","year":"2015","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.cell.2018.06.025_bib22","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/nature12688","article-title":"A melanocyte lineage program confers resistance to MAP kinase pathway inhibition","volume":"504","author":"Johannessen","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.cell.2018.06.025_bib23","doi-asserted-by":"crossref","first-page":"5937","DOI":"10.1158\/0008-5472.CAN-14-1174","article-title":"Phenotype switching: tumor cell plasticity as a resistance mechanism and target for therapy","volume":"74","author":"Kemper","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.cell.2018.06.025_bib24","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nmeth.2967","article-title":"Bayesian approach to single-cell differential expression analysis","volume":"11","author":"Kharchenko","year":"2014","journal-title":"Nat. Methods"},{"issue":"D1","key":"10.1016\/j.cell.2018.06.025_bib25","doi-asserted-by":"crossref","first-page":"D959","DOI":"10.1093\/nar\/gkv1128","article-title":"ccmGDB: a database for cancer cell metabolism genes","volume":"44","author":"Kim","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cell.2018.06.025_bib26","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1158\/2159-8290.CD-13-0424","article-title":"A melanoma cell state distinction influences sensitivity to MAPK pathway inhibitors","volume":"4","author":"Konieczkowski","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.cell.2018.06.025_bib27","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.stem.2015.07.002","article-title":"Single-Cell transcriptomics reveals a population of dormant neural stem cells that become activated upon brain injury","volume":"17","author":"Llorens-Bobadilla","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.cell.2018.06.025_bib28","doi-asserted-by":"crossref","first-page":"5694","DOI":"10.1038\/ncomms6694","article-title":"Increased MAPK reactivation in early resistance to dabrafenib\/trametinib combination therapy of BRAF-mutant metastatic melanoma","volume":"5","author":"Long","year":"2014","journal-title":"Nat. Comm."},{"key":"10.1016\/j.cell.2018.06.025_bib29","first-page":"2122","article-title":"A step-by-step workflow for low-level analysis of single-cell RNA-seq data with Bioconductor","volume":"5","author":"Lun","year":"2016","journal-title":"F1000Res."},{"key":"10.1016\/j.cell.2018.06.025_bib30","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrc.2017.125","article-title":"Targeting minimal residual disease: a path to cure?","volume":"18","author":"Luskin","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cell.2018.06.025_bib31","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1038\/nprot.2016.138","article-title":"Separation and parallel sequencing of the genomes and transcriptomes of single cells using G&T-seq","volume":"11","author":"Macaulay","year":"2016","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.cell.2018.06.025_bib32","first-page":"849","article-title":"Conditional deletion of AP-2\u03b2 in mouse cranial neural crest results in anterior segment dysgenesis and early-onset glaucoma","volume":"9","author":"Martino","year":"2016","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.cell.2018.06.025_bib33","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/bioinformatics\/btw777","article-title":"Scater: pre-processing, quality control, normalization and visualization of single-cell RNA-seq data in R","volume":"33","author":"McCarthy","year":"2017","journal-title":"Bioinformatics"},{"key":"10.1016\/j.cell.2018.06.025_bib34","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.1038\/onc.2014.432","article-title":"A stress-induced early innate response causes multidrug tolerance in melanoma","volume":"34","author":"Menon","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.cell.2018.06.025_bib35","doi-asserted-by":"crossref","first-page":"5712","DOI":"10.1038\/ncomms6712","article-title":"Low MITF\/AXL ratio predicts early resistance to multiple targeted drugs in melanoma","volume":"5","author":"M\u00fcller","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2018.06.025_bib36","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nprot.2014.006","article-title":"Full-length RNA-seq from single cells using Smart-seq2","volume":"9","author":"Picelli","year":"2014","journal-title":"Nat. Protoc."},{"issue":"W1","key":"10.1016\/j.cell.2018.06.025_bib37","doi-asserted-by":"crossref","first-page":"W72","DOI":"10.1093\/nar\/gkv529","article-title":"StemChecker: a web-based tool to discover and explore stemness signatures in gene sets","volume":"43","author":"Pinto","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cell.2018.06.025_bib38","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1038\/bjc.2015.146","article-title":"Non-genetic cancer cell plasticity and therapy-induced stemness in tumour relapse: \u2018What does not kill me strengthens me\u2019","volume":"112","author":"Pisco","year":"2015","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.cell.2018.06.025_bib39","doi-asserted-by":"crossref","first-page":"e92596","DOI":"10.1371\/journal.pone.0092596","article-title":"The nerve growth factor receptor CD271 is crucial to maintain tumorigenicity and stem-like properties of melanoma cells","volume":"9","author":"Redmer","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cell.2018.06.025_bib40","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1158\/1078-0432.CCR-13-3122","article-title":"BRAF inhibitor resistance mechanisms in metastatic melanoma: spectrum and clinical impact","volume":"20","author":"Rizos","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cell.2018.06.025_bib41","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.ccr.2013.05.003","article-title":"Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1B(high) cells","volume":"23","author":"Roesch","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2018.06.025_bib42","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature22794","article-title":"Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance","volume":"546","author":"Shaffer","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.cell.2018.06.025_bib43","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cell.2010.02.027","article-title":"A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations","volume":"141","author":"Sharma","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.cell.2018.06.025_bib44","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ccell.2016.02.003","article-title":"Inhibiting drivers of non-mutational drug tolerance is a salvage strategy for targeted melanoma therapy","volume":"29","author":"Smith","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2018.06.025_bib45","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/jnci\/djs471","article-title":"Effect of SMURF2 targeting on susceptibility to MEK inhibitors in melanoma","volume":"105","author":"Smith","year":"2013","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.cell.2018.06.025_bib46","doi-asserted-by":"crossref","first-page":"13679","DOI":"10.1073\/pnas.1712064115","article-title":"Single-cell analysis resolves the cell state transition and signaling dynamics associated with melanoma drug-induced resistance","volume":"114","author":"Su","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2018.06.025_bib47","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1126\/science.aad0501","article-title":"Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq","volume":"352","author":"Tirosh","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.cell.2018.06.025_bib48","doi-asserted-by":"crossref","first-page":"16028","DOI":"10.1038\/celldisc.2016.28","article-title":"JUN dependency in distinct early and late BRAF inhibition adaptation states of melanoma","volume":"2","author":"Titz","year":"2016","journal-title":"Cell Discov."},{"key":"10.1016\/j.cell.2018.06.025_bib49","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nbt.2859","article-title":"The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells","volume":"32","author":"Trapnell","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cell.2018.06.025_bib50","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ncponc1110","article-title":"Mechanisms of disease: cancer stem cells--targeting the evil twin","volume":"5","author":"Trumpp","year":"2008","journal-title":"Nat. Clin. Pract. Oncol."},{"key":"10.1016\/j.cell.2018.06.025_bib51","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.celrep.2017.03.037","article-title":"Quantitative multiplex immunohistochemistry reveals myeloid-inflamed tumor-immune complexity associated with poor prognosis","volume":"19","author":"Tsujikawa","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.cell.2018.06.025_bib52","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1158\/2159-8290.CD-13-0617","article-title":"The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma","volume":"4","author":"Van Allen","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.cell.2018.06.025_bib53","doi-asserted-by":"crossref","first-page":"6683","DOI":"10.1038\/ncomms7683","article-title":"Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state","volume":"6","author":"Verfaillie","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2018.06.025_bib54","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","article-title":"Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1","volume":"17","author":"Verhaak","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2018.06.025_bib55","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/pcmr.12370","article-title":"Microphthalmia-associated transcription factor in melanoma development and MAP-kinase pathway targeted therapy","volume":"28","author":"Wellbrock","year":"2015","journal-title":"Pigment Cell Melanoma Res."}],"container-title":["Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867418307931?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867418307931?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T11:33:32Z","timestamp":1758800012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0092867418307931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0092867418307931"],"URL":"https:\/\/doi.org\/10.1016\/j.cell.2018.06.025","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.733626181.793575378","asserted-by":"object"}]},"ISSN":["0092-8674"],"issn-type":[{"value":"0092-8674","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toward Minimal Residual Disease-Directed Therapy in Melanoma","name":"articletitle","label":"Article Title"},{"value":"Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cell.2018.06.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}